Related Experiment Video
Updated: Jul 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Induction of apoptosis in melanoma cell lines by p53 and its related proteins
T Yamashita1, T Tokino, H Tonoki
1Department of Dermatology, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo, Japan. yamasita@sapmed.ac.jp
Abstract:
Melanoma cells rarely contain mutant p53 and hardly undergo apoptosis by wild-type p53. By using recombinant adenoviruses that express p53 or p53-related p51A or p73beta, we tested their apoptotic activities in melanoma cells. Yeast functional assay revealed a mutation of p53 at the 258th codon (AAA [K] instead of GAA [E]) in one cell line, 70W, out of six human melanoma cell lines analyzed (SK-mel-23, SK-mel-24, SK-mel-118, TXM18, 70W, and G361). Adenovirus-mediated transfer of p53, p51A, and/or p73beta suppressed growth and induced apoptotic DNA fragmentation of SK-mel-23, SK-mel-118, and 70W cells. Interestingly, p51A induced DNA fragmentation in them more significantly than p53 and p73beta. By Western blotting we analyzed levels of apoptosis-related proteins in cells expressing p53 family members. Apoptotic Bax and antiapoptotic Bcl-2 were not significantly upregulated or downregulated by expression of p53, p51A, or p73beta, except for p53-expressing 70W cells, which contained a larger amount of Bax protein than LacZ-expressing cells. Activation of caspase-3 was demonstrated only in p51A-expressing SK-mel-118 cells. We show here that p51A can mediate apoptosis in both wild-type and mutant p53-expressing melanoma cells more significantly than p53 and p73beta. It is also suggested that in melanoma cells (i) cellular target protein(s) other than Bcl-2 and Bax might be responsible for induction of p51A-mediated apoptosis and (ii) caspase-3 is not always involved in the apoptosis by p53 family members.
Insights
The p53 family member p51A effectively induces apoptosis in melanoma cells, regardless of p53 status. This finding offers new therapeutic avenues for melanoma treatment by targeting apoptosis pathways.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma cells typically exhibit wild-type p53 and resist apoptosis.
- Understanding p53 family member roles in melanoma apoptosis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the apoptotic activities of p53, p51A, and p73beta in human melanoma cells.
- To identify potential therapeutic targets for inducing apoptosis in melanoma.
Main Methods:
- Utilized recombinant adenoviruses to express p53, p51A, and p73beta in six human melanoma cell lines.
- Performed yeast functional assays to detect p53 mutations.
- Analyzed apoptosis induction via DNA fragmentation and Western blotting for apoptosis-related proteins (Bax, Bcl-2) and caspase-3 activation.
Main Results:
- Adenovirus-mediated transfer of p53, p51A, and p73beta suppressed growth and induced apoptosis in susceptible melanoma cells.
- p51A demonstrated significantly higher apoptotic activity than p53 and p73beta.
- Caspase-3 activation was observed only in p51A-expressing cells, suggesting alternative apoptotic pathways.
Conclusions:
- p51A is a potent inducer of apoptosis in both wild-type and mutant p53 melanoma cells, outperforming p53 and p73beta.
- Melanoma apoptosis induced by p51A may involve targets other than Bcl-2 and Bax.
- Caspase-3 is not universally required for apoptosis mediated by p53 family members in melanoma.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle

